Highlights
About
Insulin Treatment Method
Insuline Medical is focused on improving the performance of current insulin treatment methods by better utilizing human physiology. Its flagship product, the InsuPad, is composed of a disposable injection window (Fenster) and a reusable, rechargeable control unit using skin-condition stabilization technology. By gently warming the skin, the device increases blood flow, helping the body absorb insulin more quickly and effectively. InsuPad is noninvasive, safe, simple, easy to use, and has Medical Device Directive (CE mark) approval for the European Union. Insuline's InsuPad offers significant clinical benefits to patients, physicians, and health insurance providers. Insuline Medical has initiated commercialization in Germany in collaboration with J&J (LifeScan) and in Israel with DYN diagnostics, exclusive representatives of Roche Diagnostics in Israel.
Identity
| Name | InsuLine Medical |
|---|---|
| Slug | insuline-medical |
| Type / kind | startup |
| Crunchbase ID | insuline-medical |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6steMJDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Jun 2019 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | Ya'akov Eliav Street 5, Jerusalem, Israel |
Web & social
| https://www.linkedin.com/company/1461439 | |
| YouTube | https://www.youtube.com/channel/UC7SawJxDF5S9CSaIjnuA-wA |
Classifications
Funding
| Total raised | $6.5M |
|---|---|
| Current stage | Mature |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}